Shri Ahimsa Naturals IPO Details
Shri Ahimsa Naturals is set to launch its Initial Public Offering (IPO) from March 25 to March 27, 2025, aiming for a listing on the NSE SME exchange. Shri Ahimsa Naturals IPO comprises 62,02,800 shares, amounting to ₹73.81 crore. This includes a fresh issue of 42,03,600 shares valued at ₹50.02 crore and an offer for sale (OFS) of 19,99,200 shares at a face value of ₹10 per share, totaling ₹23.79 crore.
The issue price band is set between ₹113 to ₹119 per share, with a minimum lot size of 1,200 shares. Pre-issue, the company’s shareholding stood at 1,91,26,500 shares, which will increase to 2,33,30,100 shares post-issue.Furthermore, 3,12,000 shares have been reserved for market-making, with Choice Equity Broking Private Limited overseeing the process.
This book-built IPO is intended to fund business expansion, meet working capital needs, and support general corporate purposes. Investors keen on SME opportunities should evaluate the company’s financials and growth potential before subscribing.
Shri Ahimsa Naturals IPO Important Dates
Shri Ahimsa Naturals IPO will be open for subscription from March 25 to March 27, 2025. The expected allotment date for shares is March 28, 2025, followed by the initiation of refunds on April 1, 2025 for unsuccessful applicants. The credit of shares to Demat accounts is expected on the same day, April 1, 2025. The expected listing date on the NSE SME exchange is set for April 2, 2025. Investors must ensure UPI mandate confirmation before the cut-off time of 5 PM on March 27, 2025, to secure their application.
Shri Ahimsa Naturals IPO Reservation
The Shri Ahimsa Naturals IPO has a structured reservation system for different categories of investors. Qualified Institutional Buyers (QIBs) can be allotted up to 50% of the net offer, ensuring institutional participation. Retail Individual Investors (RIIs) have a minimum allocation of 35% of the net offer, making it accessible to small investors. Meanwhile, Non-Institutional Investors (NIIs) or High Net Worth Individuals (HNIs) are allocated a minimum of 15% of the net offer. This structured allocation promotes fair distribution among investor categories while supporting market liquidity and stability.
Shri Ahimsa Naturals IPO Lot Size
The Shri Ahimsa Naturals IPO requires investors to bid for a minimum of 1,200 shares, with additional bids in multiples thereof. Retail investors can apply for a minimum and maximum of 1 lot (1,200 shares), amounting to ₹1,42,800. High Net Worth Individuals (HNI) must bid for at least 2 lots (2,400 shares), requiring a minimum investment of ₹2,85,600.
Overview of Shri Ahimsa Naturals Limited
Founded in 1990, Shri Ahimsa Naturals Limited is engaged in the extraction and production of Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine. Its products cater to multiple industries, including food & beverages, nutraceuticals, cosmetics, and pharmaceuticals, owing to their numerous health advantages.
Active Infrastructures IPO: Complete Analysis of A ₹77.83 crore SME IPO
Product Offerings:
- Natural Caffeine: Extracted from the seeds of coffee and tea plants, this ingredient is extensively used in energy drinks, soft beverages, skincare, and medicinal formulations.
- Green Coffee Bean Extract: Sourced from unroasted green coffee seeds, this extract is abundant in chlorogenic acid, recognized for its antioxidant effects and potential role in weight management.
Manufacturing & Certifications:
The company operates a state-of-the-art manufacturing facility in Jaipur, Rajasthan, ensuring adherence to international quality benchmarks. It holds certifications such as:
- ISO 9001:2015 – Quality Management System
- ISO 22000:2018 – Food Safety Standards
- ISO 45001:2018 – Occupational Health & Safety Measures
- ISO 14001:2015 – Environmental Safety Standards
- HACCP & GMP-compliant processes to maintain product excellence.
Global Presence & Financial Performance:
Shri Ahimsa Naturals exports its products to several international markets, including the USA, Germany, South Korea, the UK, and Thailand. The company has demonstrated consistent export revenue growth, reporting:
- ₹9,988.01 lakh in Fiscal Year 2023
- ₹7,463.71 lakh in Fiscal Year 2022
- ₹5,633.50 lakh in Fiscal Year 2021
- ₹3,530.91 lakh as of September 30, 2024
As of March 2025, the company has a team of around 80 employees and is backed by seasoned promoters and an efficient management team, driving its continued success.
Shri Ahimsa Naturals Limited Promoters
Shri Ahimsa Naturals Limited is backed by a strong promoter group comprising Mr. Nemi Chand Jain, Mrs. Sumitra Jain, Mr. Amit Kumar Jain, Mr. Sumit Jain, and Mrs. Prerna Jain, along with Ahimsa Holdings Private Limited and Bimneer Investments Private Limited. These promoters collectively held a pre-issue stake of 94.22% in the company, reflecting their significant control and vested interest in its growth and long-term vision.
Shri Ahimsa Naturals Limited Financials
Shri Ahimsa Naturals Limited has shown significant financial growth over the years. As of September 30, 2024, the company’s total assets stood at ₹111.39 crore, up from ₹103.15 crore at the end of March 2024 and ₹40.34 crore in March 2022. The company reported revenue of ₹41.37 crore for the half-year ending September 2024, compared to ₹78.7 crore in FY24 and ₹106.14 crore in FY23. Profit after tax (PAT) has shown fluctuations, standing at ₹9.74 crore in the latest period, down from ₹18.67 crore in FY24 and ₹38.21 crore in FY23.
Despite this, the company’s net worth has grown steadily, reaching ₹99.67 crore as of September 2024, driven by reserves and a surplus of ₹80.54 crore. Additionally, total borrowings have declined significantly to ₹4.85 crore from ₹13.83 crore in FY24. This financial trajectory underscores the company’s expansion, profitability trends, and strengthening financial position.
Shri Ahimsa Naturals IPO Objectives
Shri Ahimsa Naturals Limited intends to allocate the net proceeds from its IPO for expansion and corporate needs. The company plans to invest ₹35 crore in its wholly-owned subsidiary, Shri Ahimsa Healthcare Private Limited (SAHPL), to establish a manufacturing facility in Sawarda, Jaipur, Rajasthan. Additionally, a portion of the funds will be utilized for general corporate purposes, ensuring smooth business operations and future growth. This IPO is expected to enhance the company’s financial strength and manufacturing capabilities.
Shri Ahimsa Naturals IPO Registrar
The registrar for Shri Ahimsa Naturals IPO is Cameo Corporate Services Limited. Investors can contact the registrar for IPO-related queries through the following details:
- Phone: +91-44-28460390
- Email: info@shriahimsa.com
- Website: https://ipo.cameoindia.com/
Cameo Corporate Services Limited is responsible for handling IPO applications, allotment processes, and investor services related to the Shri Ahimsa Naturals IPO.
For More Details Check Documents on NSE
Disclaimer: This content is intended solely for educational and informational purposes and should not be interpreted as financial or investment advice. The information presented is derived from publicly available sources and independent analysis; however, its accuracy or completeness is not guaranteed. Readers are encouraged to conduct their own due diligence and seek guidance from a professional financial advisor before making any investment decisions. Neither the author nor stoxmail.com assumes responsibility for any financial losses or investment actions taken based on this article.